Skip to main content

CVS HEALTH Corp income statement

  • CVS · NYSE
  • Retail
  • Health Care Services
  • S&P 500
$89.35−0.49%Close 13 Nov 2026 · Market value $113.1B

CVS HEALTH Corp reported revenue of $402.1 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 7.8% from fiscal 2024. Net income was $1.77 billion and diluted earnings per share $1.39.

From CVS HEALTH Corp's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

CVS HEALTH Corp income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$76.33B$87.47B$98.22B$95.78B$107.1B$123.1B$126.8B$139.4B$153.3B$177.5B$184.8B$194.6B$256.8B$268.7B$292.1B$322.5B$357.8B$372.8B$402.1B$420.6B
Revenue growth—+14.6%+12.3%−2.5%+11.8%+15.0%+3.0%+9.9%+10.0%+15.8%+4.1%+5.3%+32.0%+4.6%+8.7%+10.4%+10.9%+4.2%+7.8%—
Net interest income−$435.0M−$509.0M−$525.0M−$536.0M−$584.0M−$557.0M−$509.0M−$600.0M−$838.0M−$1.06B−$1.04B−$536.0M$0.00$0.00——————
Cost of revenue$60.22B$69.18B$77.86B$75.56B$86.52B$100.6B$103.0B$114.0B$126.8B$148.7B$156.2B—————————
Gross profit$16.11B$18.29B$20.36B$20.22B$20.56B$22.49B$23.78B$25.37B$26.53B$28.86B$28.55B—————————
Gross margin21.1%20.9%20.7%21.1%19.2%18.3%18.8%18.2%17.3%16.3%15.4%—————————
Operating expenses$11.31B$12.24B$13.93B$14.08B$14.23B$15.28B$15.75B$16.57B$17.05B$18.45B$18.81B$21.37B$33.54B———————
Operating income$4.79B$6.05B$6.42B$6.14B$6.33B$7.21B$8.04B$8.80B$9.47B$10.39B$9.54B$4.02B$11.99B$13.91B$13.31B$7.95B$13.74B$8.52B$4.66B$15.06B
Operating margin6.3%6.9%6.5%6.4%5.9%5.9%6.3%6.3%6.2%5.8%5.2%2.1%4.7%5.2%4.6%2.5%3.8%2.3%1.2%3.6%
Interest expense—$530.0M$530.0M$539.0M$588.0M$561.0M$517.0M$615.0M$859.0M$1.08B$1.06B$2.62B$3.04B$2.91B$2.50B$2.29B$2.66B$2.96B$3.12B$3.06B
Income before tax$4.36B$5.54B$5.90B$5.60B$5.75B$6.30B$7.53B$7.68B$8.62B$8.64B$8.27B$1.41B$9.00B$9.77B$10.54B$5.84B$11.17B$6.15B$2.14B$12.12B
Income tax expense$1.72B$2.19B$2.20B$2.18B$2.26B$2.44B$2.93B$3.03B$3.39B$3.32B$1.64B$2.00B$2.37B$2.57B$2.55B$1.51B$2.81B$1.56B$408.0M$1.07B
Effective tax rate39.5%39.6%37.3%38.9%39.3%38.6%38.9%39.5%39.3%38.4%19.8%142%26.3%26.3%24.2%25.9%25.1%25.4%19.1%8.8%
Net income$2.64B$3.20B$3.70B$3.43B$3.46B$3.86B$4.59B$4.64B$5.24B$5.32B$6.62B−$594.0M$6.63B$7.18B$8.00B$4.31B$8.34B$4.61B$1.77B$11.04B
Net margin3.5%3.7%3.8%3.6%3.2%3.1%3.6%3.3%3.4%3.0%3.6%−0.3%2.6%2.7%2.7%1.3%2.3%1.2%0.4%2.6%
Net income to common shareholders—$3.20B$3.70B$3.43B$3.46B$3.86B$4.59B$4.64B$5.24B—————$8.00B$4.31B$8.34B$4.61B$1.77B$11.04B
EPS · diluted$1.92$2.18$2.55$2.49$2.57$3.02$3.74$3.96$4.63$4.90$6.44−$0.57$5.08$5.46$6.02$3.26$6.47$3.66$1.39$8.58
Diluted weighted average shares1.4B1.5B1.4B1.4B1.3B1.3B1.2B1.2B1.1B1.1B1.0B1.0B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B
Basic weighted average shares1.3B1.4B1.4B1.4B1.3B1.3B1.2B1.2B1.1B1.1B1.0B1.0B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B
EBITDA$5.89B$7.32B$7.81B$7.61B$7.90B$8.96B$9.91B$10.73B$11.57B$12.86B$12.02B$6.74B$16.36B$18.35B$17.80B$12.18B$18.11B$13.11B$9.27B$19.58B
EBITDA margin7.7%8.4%8.0%7.9%7.4%7.3%7.8%7.7%7.5%7.2%6.5%3.5%6.4%6.8%6.1%3.8%5.1%3.5%2.3%4.7%
Depreciation & amortization$1.09B$1.27B$1.39B$1.47B$1.57B$1.75B$1.87B$1.93B$2.09B$2.48B$2.48B$2.72B$4.37B$4.44B$4.49B$4.22B$4.37B$4.60B$4.61B$4.52B
Stock-based compensation$78.00M$92.00M$165.0M$150.0M$135.0M$132.0M$141.0M$165.0M$230.0M$222.0M$234.0M$280.0M$453.0M$400.0M$484.0M$447.0M$588.0M$540.0M$535.0M$745.0M
Dividends per share$0.23$0.26$0.30$0.35$0.50$0.65$0.90$1.10$1.40$1.70$2.00$2.00$2.00$2.00$2.00$2.20$2.42$2.66$2.66$2.66

Quarterly

CVS HEALTH Corp income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$93.81B$88.44B$91.23B$95.43B$97.71B$94.59B$98.92B$102.9B$105.7B$100.4B$106.1B$108.4B
Operating income$3.37B$2.27B$3.04B$832.0M$2.37B$3.37B$2.38B−$3.21B$2.11B$4.68B$4.70B$3.57B
Operating margin3.6%2.6%3.3%0.9%2.4%3.6%2.4%−3.1%2.0%4.7%4.4%3.3%
Interest expense$690.0M$716.0M$732.0M$752.0M$758.0M$785.0M$763.0M$784.0M$787.0M$774.0M$757.0M$747.0M
Income before tax$2.71B$1.58B$2.34B$105.0M$2.13B$2.62B$1.65B−$3.48B$1.35B$3.94B$3.98B$2.85B
Income tax expense$658.0M$456.0M$569.0M$34.00M$503.0M$835.0M$634.0M$508.0M−$1.57B$981.0M$982.0M$678.0M
Effective tax rate24.3%28.9%24.3%32.4%23.7%31.9%38.5%−14.6%−116%24.9%24.7%23.8%
Net income$2.05B$1.11B$1.77B$87.00M$1.64B$1.78B$1.02B−$3.98B$2.94B$2.94B$2.98B$2.17B
Net margin2.2%1.3%1.9%0.1%1.7%1.9%1.0%−3.9%2.8%2.9%2.8%2.0%
Net income to common shareholders$2.05B$1.11B$1.77B$87.00M$1.64B$1.78B$1.02B−$3.98B$2.94B$2.94B$2.98B$2.17B
EPS · diluted$1.58$0.88$1.41$0.07$1.30$1.41$0.80−$3.13$2.29$2.30$2.31$1.68
Diluted weighted average shares1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B
Basic weighted average shares1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B
EBITDA$4.51B$3.41B$4.20B$1.99B$3.52B$4.53B$3.55B−$2.07B$3.26B$5.79B$5.83B$4.70B
EBITDA margin4.8%3.9%4.6%2.1%3.6%4.8%3.6%−2.0%3.1%5.8%5.5%4.3%
Depreciation & amortization$1.13B$1.14B$1.15B$1.16B$1.15B$1.15B$1.17B$1.13B$1.15B$1.11B$1.13B$1.13B
Stock-based compensation$127.0M$137.0M$133.0M$133.0M$137.0M$126.0M$136.0M$138.0M$135.0M$266.0M$176.0M$168.0M
Dividends per share$0.60$0.67$0.67$0.67$0.67$0.67$0.67$0.67$0.67$0.67$0.67$0.67

The main figures as JSON and plain text. See data and methodology.

CVS in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.